Vital Signs Market Research Reports

Subscribe to RSS Feed
  1. This issue of Vital Signs, released on May 9, 2011, provides a strategic insight on the future of neurological drugs market. Additionally, a company spotlight is provided for AcelRx, a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. Reimb...

    $1,500.00

    Special Price $1,125.00 save 25 %

  2. 25 Apr 2011  |  North America  |  Market Research

    Vital Signs - Benchtop Automation: Accelerating Bench to Bedside

     

    This issue of Vital Signs, released on April 25, 2011, provides analyts's summary of the American Association of Cancer Research (AACR) annual meeting. Additionally, a company spotlight is provided for QuantaLife, a venture-backed startup company based in Pleasanton, Calif., developing third-generation of Polymerase Chain Reaction (PCR) technol...

    $1,500.00

    Special Price $1,125.00 save 25 %

  3. 19 Apr 2011  |  North America  |  Market Research

    Vital Signs - The Analyst's Perspective (TAP) - Issue 3

     

    This issue of Vital Signs, released on April 19, 2011, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharmaceuticals and Biotechnology, Medical Devices, In Vitro Diagnostics, Telehealth, Healthcare IT and Life Science Research Tools.

    $1,500.00

    Special Price $1,125.00 save 25 %

  4. 11 Apr 2011  |  North America  |  Market Research

    Vital Signs - Plotting the Telehealth Market Spectrum

     

    This issue of Vital Signs, released on April 11, 2011, provides a strategic insight on the telehealth market. Additionally, a company spotlight is provided for Cardiocom, a company that prominently works on diabetes and cardiac monitoring solutions. Reimbursement and regulatory news from the FDA is also provided for week of March 21, 2011.

    $1,500.00

    Special Price $1,125.00 save 25 %

  5. 31 Mar 2011  |  North America  |  Market Research

    Vital Signs - Vaccines - The Sustainable Blockbuster Business

     

    This issue of Vital Signs, released on March 31, 2011, provides a strategic insight on the vaccines market. Additionally, a company spotlight is provided for Health Decisions, a CRO that has built a flexible global trial network that offers a structured, technology-backed clinical trial management model that focuses on improving speed and produ...

    $1,500.00

    Special Price $1,125.00 save 25 %

  6. 21 Mar 2011  |  North America  |  Market Research

    Vital Signs - The Analyst's Perspective (TAP) - Issue 2

     

    This issue of Vital Signs, released on March 21, 2011, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharmaceuticals and Biotechnology, Medical Devices, In Vitro Diagnostics and Life Science Research Tools.

    $1,500.00

    Special Price $1,125.00 save 25 %

  7. 14 Mar 2011  |  North America  |  Market Research

    Vital Signs - 2010 Mergers and Acquisition (M&A) Activity in Healthcare Markets

     

    This issue of Vital Signs, released on March 14, 2011, provides a strategic insight on the mergers and acquisitions activity in healthcare markets in 2010. Additionally, a company spotlight is provided for GI Dynamics, an early stage medical device company that is developing novel approaches to treat obesity.Reimbursement and regulatory news from t...

    $1,500.00

    Special Price $1,125.00 save 25 %

  8. This issue of Vital Signs, released on February 21, 2011, provides a strategic insight on how cancer diagnostic companies can reach out to their customer base. Additionally, a company spotlight is provided for BioMarker Strategies, a novel tissue-based cancer diagnostics company that is developing the SnapPathTM ex vivo biomarker platform to improv...

    $1,500.00

    Special Price $1,125.00 save 25 %

  9. 14 Feb 2011  |  North America  |  Market Research

    Vital Signs - The Analyst's Perspective (TAP) - Issue 1

     

    This issue of Vital Signs, released on February 14, 2011, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharmaceuticals and Biotechnology, Medical Devices, In Vitro Diagnostics and Life Science Research Tools.

    $1,500.00

    Special Price $1,125.00 save 25 %

  10. This issue of Vital Signs, released on February 7, 2011, provides a strategic overview of influences of cloud computing in the medical imaging market. Additionally, a company spotlight is provided for Biotronics3D, a novel company that distributes medical imaging services with advanced visualization productivity and analysis tools without the need ...

    $1,500.00

    Special Price $1,125.00 save 25 %